Skip to content

Age and lifestyle feature in a review of macular degeneration risk

A review identifies age and inherited susceptibility as key factors in age-related macular degeneration. Lifestyle associations are also reported, but the abstract does not quantify them or establish preventive effects.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

The review identifies age as the strongest risk factor for early and advanced age-related macular degeneration, with inherited susceptibility also playing a role. Smoking, dietary patterns, and physical activity were linked to risk. These epidemiological associations describe relationships in studied populations; they do not establish how much changing a behavior would prevent the condition.

Keep in mind

The abstract does not identify included populations, study counts, follow-up durations, or numerical risk estimates. It therefore supports a qualitative account of reported associations, rather than a quantified personal risk or prevention claim.

Different kinds of risk factors

The review considered age, genetic predisposition—meaning inherited susceptibility—and behaviors that may change over time. These are different types of factors. Their inclusion in the same review does not mean each has the same evidence or influence.

Medication findings remain tentative

The authors mention potentially favorable associations involving metformin and statins. The abstract gives no numerical estimates or study details for those findings. It does not establish that either medication prevents macular degeneration or supports a medication change.

CHECK THE ORIGINAL

The original publication

[Risk factors for age-related macular degeneration : Lessons learned from current data].

Brandl C, Heid IM, Helbig H et al.
Ophthalmologie · 2025

PubMed ID
40512437
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.